-
Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Ultimovacs ASA – Annual General Meeting held on April 18, 2024
-
Ultimovacs ASA – Annual General Meeting held on April 18, 2024
-
Ultimovacs Implements Operational Adjustments to Support Continuous Advancement of the UV1 Vaccine Phase II Program
-
Ultimovacs Implements Operational Adjustments to Support Continuous Advancement of the UV1 Vaccine Phase II Program
-
Ultimovacs ASA – Disclosure of voting rights of Annual General Meeting
-
Ultimovacs ASA – Disclosure of voting rights of Annual General Meeting
-
Ultimovacs – Invitation to Business Update on April 17, 2024
-
Ultimovacs – Invitation to Business Update on April 17, 2024
